The effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patients

OBJECTIVE: The objective of this study was to examine the effects of angiotensin-converting enzyme inhibitors on peritoneal membrane transport, peritoneal protein loss, and proteinuria in peritoneal dialysis patients. METHODS: Fifty-four peritoneal dialysis patients were included in the study. The patients were divided into two groups. Group 1 (n = 34) was treated with angiotensin-converting enzyme inhibitors. Group 2 (n = 20) did not receive any antihypertensive drugs during the entire follow-up. Eleven patients were excluded from the study thereafter. Thus, a total of 30 patients in Group 1 and 13 patients in Group 2 completed the study. We observed the patients for six months. Group 1 patients received maximal doses of angiotensin-converting enzyme inhibitors for six months. Parameters at the beginning of study and at the end of six months were evaluated. RESULTS: At the end of six months, total peritoneal protein loss in 24-hour dialysate effluent was significantly decreased in Group 1, whereas it was increased in Group 2. Compared to the baseline level, peritoneal albumin loss in 24-hour dialysate effluent and 4-hour D/P creatinine were significantly increased in Group 2 but were not significantly changed in Group 1. A covariance analysis between the groups revealed a significant difference only in the decreased amount of total protein loss in 24-hour dialysate. Proteinuria was decreased significantly in Group 1. CONCLUSION: This study suggests that angiotensin-converting enzyme inhibitors reduce peritoneal protein loss and small-solute transport and effectively protect peritoneal membrane transport in peritoneal dialysis patients.

Saved in:
Bibliographic Details
Main Authors: Basturk,Taner, Unsal,Abdulkadir, Koc,Yener, Nezaket,Eren, Ahbap,Elbis, Sakaci,Tamer, Sevinc,Mustafa
Format: Digital revista
Language:English
Published: Faculdade de Medicina / USP 2012
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322012000800004
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1807-59322012000800004
record_format ojs
spelling oai:scielo:S1807-593220120008000042012-08-30The effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patientsBasturk,TanerUnsal,AbdulkadirKoc,YenerNezaket,ErenAhbap,ElbisSakaci,TamerSevinc,Mustafa Angiotensin-converting enzyme inhibitors peritoneal protein loss peritoneal transport OBJECTIVE: The objective of this study was to examine the effects of angiotensin-converting enzyme inhibitors on peritoneal membrane transport, peritoneal protein loss, and proteinuria in peritoneal dialysis patients. METHODS: Fifty-four peritoneal dialysis patients were included in the study. The patients were divided into two groups. Group 1 (n = 34) was treated with angiotensin-converting enzyme inhibitors. Group 2 (n = 20) did not receive any antihypertensive drugs during the entire follow-up. Eleven patients were excluded from the study thereafter. Thus, a total of 30 patients in Group 1 and 13 patients in Group 2 completed the study. We observed the patients for six months. Group 1 patients received maximal doses of angiotensin-converting enzyme inhibitors for six months. Parameters at the beginning of study and at the end of six months were evaluated. RESULTS: At the end of six months, total peritoneal protein loss in 24-hour dialysate effluent was significantly decreased in Group 1, whereas it was increased in Group 2. Compared to the baseline level, peritoneal albumin loss in 24-hour dialysate effluent and 4-hour D/P creatinine were significantly increased in Group 2 but were not significantly changed in Group 1. A covariance analysis between the groups revealed a significant difference only in the decreased amount of total protein loss in 24-hour dialysate. Proteinuria was decreased significantly in Group 1. CONCLUSION: This study suggests that angiotensin-converting enzyme inhibitors reduce peritoneal protein loss and small-solute transport and effectively protect peritoneal membrane transport in peritoneal dialysis patients.info:eu-repo/semantics/openAccessFaculdade de Medicina / USPClinics v.67 n.8 20122012-08-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322012000800004en10.6061/clinics/2012(08)04
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Basturk,Taner
Unsal,Abdulkadir
Koc,Yener
Nezaket,Eren
Ahbap,Elbis
Sakaci,Tamer
Sevinc,Mustafa
spellingShingle Basturk,Taner
Unsal,Abdulkadir
Koc,Yener
Nezaket,Eren
Ahbap,Elbis
Sakaci,Tamer
Sevinc,Mustafa
The effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patients
author_facet Basturk,Taner
Unsal,Abdulkadir
Koc,Yener
Nezaket,Eren
Ahbap,Elbis
Sakaci,Tamer
Sevinc,Mustafa
author_sort Basturk,Taner
title The effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patients
title_short The effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patients
title_full The effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patients
title_fullStr The effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patients
title_full_unstemmed The effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patients
title_sort effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patients
description OBJECTIVE: The objective of this study was to examine the effects of angiotensin-converting enzyme inhibitors on peritoneal membrane transport, peritoneal protein loss, and proteinuria in peritoneal dialysis patients. METHODS: Fifty-four peritoneal dialysis patients were included in the study. The patients were divided into two groups. Group 1 (n = 34) was treated with angiotensin-converting enzyme inhibitors. Group 2 (n = 20) did not receive any antihypertensive drugs during the entire follow-up. Eleven patients were excluded from the study thereafter. Thus, a total of 30 patients in Group 1 and 13 patients in Group 2 completed the study. We observed the patients for six months. Group 1 patients received maximal doses of angiotensin-converting enzyme inhibitors for six months. Parameters at the beginning of study and at the end of six months were evaluated. RESULTS: At the end of six months, total peritoneal protein loss in 24-hour dialysate effluent was significantly decreased in Group 1, whereas it was increased in Group 2. Compared to the baseline level, peritoneal albumin loss in 24-hour dialysate effluent and 4-hour D/P creatinine were significantly increased in Group 2 but were not significantly changed in Group 1. A covariance analysis between the groups revealed a significant difference only in the decreased amount of total protein loss in 24-hour dialysate. Proteinuria was decreased significantly in Group 1. CONCLUSION: This study suggests that angiotensin-converting enzyme inhibitors reduce peritoneal protein loss and small-solute transport and effectively protect peritoneal membrane transport in peritoneal dialysis patients.
publisher Faculdade de Medicina / USP
publishDate 2012
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322012000800004
work_keys_str_mv AT basturktaner theeffectsofangiotensinconvertingenzymeinhibitorsonperitonealproteinlossandsolutetransportinperitonealdialysispatients
AT unsalabdulkadir theeffectsofangiotensinconvertingenzymeinhibitorsonperitonealproteinlossandsolutetransportinperitonealdialysispatients
AT kocyener theeffectsofangiotensinconvertingenzymeinhibitorsonperitonealproteinlossandsolutetransportinperitonealdialysispatients
AT nezaketeren theeffectsofangiotensinconvertingenzymeinhibitorsonperitonealproteinlossandsolutetransportinperitonealdialysispatients
AT ahbapelbis theeffectsofangiotensinconvertingenzymeinhibitorsonperitonealproteinlossandsolutetransportinperitonealdialysispatients
AT sakacitamer theeffectsofangiotensinconvertingenzymeinhibitorsonperitonealproteinlossandsolutetransportinperitonealdialysispatients
AT sevincmustafa theeffectsofangiotensinconvertingenzymeinhibitorsonperitonealproteinlossandsolutetransportinperitonealdialysispatients
AT basturktaner effectsofangiotensinconvertingenzymeinhibitorsonperitonealproteinlossandsolutetransportinperitonealdialysispatients
AT unsalabdulkadir effectsofangiotensinconvertingenzymeinhibitorsonperitonealproteinlossandsolutetransportinperitonealdialysispatients
AT kocyener effectsofangiotensinconvertingenzymeinhibitorsonperitonealproteinlossandsolutetransportinperitonealdialysispatients
AT nezaketeren effectsofangiotensinconvertingenzymeinhibitorsonperitonealproteinlossandsolutetransportinperitonealdialysispatients
AT ahbapelbis effectsofangiotensinconvertingenzymeinhibitorsonperitonealproteinlossandsolutetransportinperitonealdialysispatients
AT sakacitamer effectsofangiotensinconvertingenzymeinhibitorsonperitonealproteinlossandsolutetransportinperitonealdialysispatients
AT sevincmustafa effectsofangiotensinconvertingenzymeinhibitorsonperitonealproteinlossandsolutetransportinperitonealdialysispatients
_version_ 1756432168105541632